Fact
MacRitchie Investments, the Temasek vehicle, along with affiliates Jongsong and V-Sciences, sold 3.56 crore Lenskart shares in the open market, according to a July 14 exchange filing. That block, 2.05% of the company, brought in close to ₹1,940 Cr, about $204 Mn. The last tranche changed hands on July 10, 72.69 lakh shares priced off that day's ₹543.30 close, leaving Temasek's direct stake down from 4.26% to 2.21%, with its combined holding across entities now at 4.75%.
Interpretation
Three institutional early backers, SoftBank, ADIA and now Temasek, selling into the same stock within weeks is a pattern with two readings. The bearish one, early money heading for the exit, is the lazier read. The likelier one, per Mint's framing, is capital recycling: a crowded IPO pipeline (Zepto, Cult.fit and InsuranceDekho are all queued) gives funds fresh deployment targets, and Lenskart's post-listing liquidity is deep enough to absorb ₹1,940 Cr in block sales without breaking the stock. That second fact is the one that matters for D2C: the public-market exit path for Indian consumer companies is now liquid enough that patient capital actually gets out.
Action
Founders raising late-stage should note the mechanics, not just the headline: Temasek exited in staged tranches through multiple entities and still kept 4.75% after selling, a staged sell-down, not a dump. If your cap table holds vintage 2016-to-2018 money, model staged secondary exits into any future listing rather than assuming lock-up-expiry cliff sales, and raise the topic with those investors before they raise it with you.
Watch next
Whether the remaining 4.75% moves in the next disclosure window, and whether the same staged-exit pattern shows up in Swiggy and FirstCry stock as the 2026 IPO pipeline gives early investors new places to put the money.